Thrombocytosis in a patient with acute promyelocytic leukemia during treatment with all‐trans retinoic acid and arsenic trioxide

Thrombocytosis in a patient with acute promyelocytic leukemia during treatment with all‐trans retinoic acid and arsenic trioxide

Abstract Thrombocytosis is an unusual side effect of all‐trans retinoic acid (ATRA) treatment that occurs in some patients with acute promyelocytic leukemia (APL).

Bibliographic Details
Main Authors:	Maryam Habibi, Reza Manouchehri Ardekani, Hossein Motedayyen
Format:	Article
Language:	English
Published:	Wiley 2021-04-01
Series:	Clinical Case Reports
Subjects:	acute promyelocytic leukemia all‐trans retinoic acid (ATRA) thrombocytosis
Online Access:	https://doi.org/10.1002/ccr3.3978

Similar Items

Treatment for acute promyelocytic leukemia during pregnancy
by: V V Troitskaia, et al.
Published: (2013-10-01)

Acute Promyelocytic Leukemia and Brugada Syndrome: A Report on the Safety of Arsenic Trioxide/All-Trans-Retinoic Acid Therapy
by: Giorgio Rosati, et al.
Published: (2023-07-01)

Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience
by: Francesco Autore, et al.
Published: (2021-07-01)

Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial
by: Xinxin Zhang, et al.
Published: (2018-09-01)

Acute Promyelocytic Leukemia in Four Year Old Female Child - A Case Report
by: Anirudha V. Kushtagi, et al.
Published: (2014-07-01)

Genital Ulcer Development in Patients with Acute Promyelocytic Leukaemia Treated with All-Trans Retinoic Acid: A Case Series
by: Mohammed Al Huneini, et al.
Published: (2013-05-01)

CD71-mediated liposomal arsenic-nickel complex combined with all-trans retinoic acid for the efficacy of acute promyelocytic leukemia
by: Xiao Liu, et al.
Published: (2023-07-01)

All-Trans Retinoic Acid-Induced Ototoxicity during Chemotherapy in Pediatric Acute Promyelocytic Leukemia
by: Jong Hyeon Lee, et al.
Published: (2021-01-01)

Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial
by: Li Zhang, et al.
Published: (2018-04-01)

Effect of all-trans retinoic acid on newly diagnosed acute promyelocytic leukemia patients: results of a Brazilian center
by: B.C. de-Medeiros, et al.
Published: (1998-12-01)

Recurrences of acute promyelocytic leukemia in children: experience with arsenic trioxide therapy and autologous hemopoietic cell transplantation
by: D D Baidildina, et al.
Published: (2010-07-01)

Blood Parameters in Treatment with Arsenic Trioxide in Acute Promyelocytic Leukemia: A Systematic Review
by: Mehdi Mohammadi Kanesbi, et al.
Published: (2020-04-01)

Multiple adverse drug reactions during all-trans retinoic acid treatment for acute promyelocytic leukemia: differentiation syndrome, bradycardia, intestinal necrosis
by: Valeria Ferla, et al.
Published: (2020-04-01)

Combination of arsenicum trioxide and all trans retinoic acid in the treatment of relapsed acute promyelocytic leukemia
by: A. N. Sokolov, et al.
Published: (2015-06-01)

Combination of arsenicum trioxide and all trans retinoic acid in the treatment of relapsed acute promyelocytic leukemia
by: A. N. Sokolov, et al.
Published: (2015-06-01)

Arteriovenous thrombosis, a complication of induction therapy with all‐trans retinoic acid for acute promyelocytic leukemia: A case report
by: Farhad Tondro Anamag, et al.
Published: (2023-09-01)

All -Trans-Retinoic Acid–induced pseudotumor cerebri in Acute Promyelocytic Leukemia
by: anoop tm
Published: (2014-08-01)

All-trans retinoic acid in hematologic disorders: not just acute promyelocytic leukemia
by: Yan Chen, et al.
Published: (2024-07-01)

A case of acute promyelocytic leukemia with morphologic multilineage dysplastic changes
by: Setsuki Isono, et al.
Published: (2013-02-01)

Treatment of adult patients with acute promyelocytic leukemia according to the AIDA protocol
by: E N Parovichnikova, et al.
Published: (2013-07-01)

The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells
by: Luciana Yamamoto de Almeida, et al.
Published: (2021-09-01)

ATRA+ATO combination in APL – A commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades” by Teng-Fei et al.
by: Damla Ortaboz, et al.
Published: (2023-03-01)

The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome
by: Dominic LaBella, et al.
Published: (2022-08-01)

Acute promyelocytic leukemia: An experience on 95 Greek patients treated in the all-trans-retinoic acid era
by: Maria Pagoni
Published: (2014-08-01)

Acute Promyelocytic Leukemia: Simplifying Treatment in a Resource Poor Setting
by: Rohan Bhise, et al.
Published: (2021-10-01)

Late differentiation syndrome in acute promyelocytic leukemia: a challenging diagnosis
by: Renata Cabral, et al.
Published: (2014-11-01)

Pharmaceutical/Clinical Strategies in the Treatment of Acute Promyelocytic Leukemia: All-Trans Retinoic Acid Encapsulation by Spray-Drying Technology as an Innovative Approach–Comprehensive Overview
by: Antónia Gonçalves, et al.
Published: (2023-01-01)

Trióxido de arsénico: una nueva luz en el tratamiento de la leucemia promielocítica Arsenic trioxide: a new light in the treatment of promyelocytic leukemia
by: Carlos Hernández Padrón, et al.
Published: (2008-08-01)

A Rare Complication in a Patient with Acute Promyelocytic Leukemia; ATRA and Posaconazole Associated Hypercalcemia
by: Yeşim Yiğit, et al.
Published: (2024-09-01)

Acute promyelocytic leukemia and differentiation therapy: molecular mechanisms of differentiation, retinoic acid resistance and novel treatments
by: Bülent Özpolat
Published: (2009-06-01)

The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions
by: Sunil Girish Iyer, et al.
Published: (2023-01-01)

ZBTB16-RARα-Positive Atypical Promyelocytic Leukemia: A Case Report
by: Laura Pardo Gambarte, et al.
Published: (2022-04-01)

Role of Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia
by: Jaime Sanz, et al.
Published: (2021-03-01)

Cost-effectiveness of the regimen proposed by the International Consortium on Acute Promyelocytic Leukemia for the treatment of newly diagnosed patients with Acute Promyelocytic Leukemia
by: Sergio Rodríguez-Rodríguez, et al.
Published: (2021-10-01)

Distinct Characteristics of Sweet’s Syndrome of the Scrotum Caused by All-trans Retinoic Acid in a Patient with Acute Promyelocytic Leukemia
by: Osamu Imataki, et al.
Published: (2021-10-01)

Optic Nerve Sheath Fenestration as Adjuvant Treatment for Severe Pseudotumor Cerebri Syndrome Induced by All-Trans Retinoic Acid
by: Kenzo Hokazono, et al.
Published: (2023-07-01)

Evolving Chemotherapy Free Regimens for Acute Promyelocytic Leukemia
by: Uday Kulkarni, et al.
Published: (2021-02-01)

A Patient with Acute Promyelocytic Leukemia Treated with Isotretinoin: A Case Report
by: Ilja Goldin, et al.
Published: (2024-10-01)

Superiority of anthracycline‐free treatment in standard‐risk acute promyelocytic leukemia: A systematic review and comparative epidemiological analysis
by: Kane Langdon, et al.
Published: (2024-03-01)

Case Report: Successful therapy with all-trans retinoic acid combined with chemotherapy followed by hematopoietic stem cell transplantation for acute promyelocytic leukemia carrying the BCOR-RARA fusion gene
by: Li Chen, et al.
Published: (2022-09-01)